Windtree Therapeutics (WINT) News Today

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

$0.42

-0.02 (-4.55%)

(As of 04/15/2024 ET)

Source

Source	Headline
	Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Significant Growth in Short Interest americanbankingnews.com - April 13 at 3:22 AM
	Windtree Therapeutics: Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing finanznachrichten.de - April 9 at 8:09 AM
	Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing globenewswire.com - April 8 at 4:48 PM
	Windtree Therapeutics Seeks Strategic Alternatives with Ladenburg Thalmann msn.com - February 2 at 1:10 AM
	Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research finance.yahoo.com - February 1 at 10:09 AM
	Windtree Therapeutics hires investment bank to explore M&A options bizjournals.com - January 31 at 1:46 PM
	Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives finance.yahoo.com - January 31 at 1:46 PM
	Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate benzinga.com - January 29 at 1:53 PM
	Windtree Therapeutics Eliminates $15 Million Contingent Liability To Deerfield Management Company finanznachrichten.de - January 26 at 7:18 PM
	Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company finance.yahoo.com - January 26 at 7:18 PM
	Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company benzinga.com - January 25 at 12:19 PM
	Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company finance.yahoo.com - January 25 at 12:19 PM
	Windtree Therapeutics Inc money.usnews.com - January 24 at 12:22 AM
	Windtree and Lee’s sign licence deal for heart failure therapy msn.com - January 18 at 3:29 PM
	Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China finance.yahoo.com - January 18 at 10:28 AM
	Windtree Therapeutics signs drug licensing deal valued at up to $138M with Chinese drug company bizjournals.com - January 17 at 6:16 PM
	Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region finance.yahoo.com - January 17 at 8:16 AM
	Hold Rating on Windtree Therapeutics Pending Key Istaroxime Studies markets.businessinsider.com - January 4 at 12:13 AM
	HC Wainwright & Co. Initiates Coverage of Windtree Therapeutics (WINT) with Neutral Recommendation msn.com - January 3 at 7:12 PM
	Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator markets.businessinsider.com - January 2 at 7:16 PM
	Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator finance.yahoo.com - January 2 at 7:16 PM
	Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024 finance.yahoo.com - December 19 at 12:07 PM
	Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock finance.yahoo.com - December 18 at 9:44 AM
	Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent finance.yahoo.com - November 16 at 8:08 AM
	Windtree TherapeuticS GAAP EPS of -$0.86 msn.com - November 9 at 10:58 PM
	Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates finance.yahoo.com - November 9 at 5:57 PM
	Windtree to Present at the Sidoti Micro Cap Conference on November 16th finance.yahoo.com - November 8 at 10:47 AM
	Windtree to Present at the ThinkEquity Conference on October 19th in New York City tmcnet.com - October 12 at 8:00 AM
	Windtree to Present at the ThinkEquity Conference on October 19th in New York City finance.yahoo.com - October 12 at 8:00 AM
	Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th finance.yahoo.com - October 10 at 9:56 AM
	Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th finance.yahoo.com - October 3 at 10:32 AM
	Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office markets.businessinsider.com - August 23 at 8:28 AM
	Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office finance.yahoo.com - August 23 at 8:28 AM
	Windtree Therapeutics (NASDAQ:WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market finance.yahoo.com - August 16 at 5:43 PM
	How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators benzinga.com - August 15 at 5:22 PM
	Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market benzinga.com - August 15 at 5:22 PM
	Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates finance.yahoo.com - August 8 at 9:18 AM
	Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure finance.yahoo.com - July 25 at 12:52 PM
	The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market finance.yahoo.com - July 18 at 12:31 PM
	Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis benzinga.com - July 14 at 12:05 PM
	Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ:WINT) Is Helping Change That finance.yahoo.com - July 14 at 12:04 PM
	Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That benzinga.com - July 12 at 1:15 PM
	Windtree Therapeutics (WINT) Price Target Decreased by 47.37% to 5.10 msn.com - July 7 at 12:24 AM
	Windtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors finance.yahoo.com - June 27 at 10:09 AM
	Windtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors finance.yahoo.com - June 27 at 10:09 AM
	Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a Group of SERCA2a Activators with a Dual Mechanism finance.yahoo.com - June 12 at 6:43 PM
	Windtree Therapeutics to Host Virtual R&D and Investor Day Focusing on the Cardiogenic Shock Market, Istaroxime, Company Strategy and Planned Near-Term Milestones finance.yahoo.com - June 5 at 11:10 AM
	Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates finance.yahoo.com - May 15 at 7:02 PM
	Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates finance.yahoo.com - May 15 at 7:02 PM
	Windtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime finance.yahoo.com - April 27 at 10:00 AM

Get Windtree Therapeutics News Delivered to You Automatically

A.I. “Perfect Storm” Could Send THESE Stocks Sky High (Ad)

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

WINT Media Mentions By Week

WINT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

WINT
News Sentiment
▼
0.65

0.66
▲
Average
Medical
News Sentiment

WINT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

WINT Articles
This Week
▼
4

1
▲
WINT Articles
Average Week

Get Windtree Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:WINT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Windtree Therapeutics (WINT) News Today

WINT Media Mentions By Week

WINT Media Sentiment

WINT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info